NSI-189 vs Semax
Overview
NSI-189 and Semax are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status.
This page compares NSI-189 and Semax across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.
Side-by-side comparison
| NSI-189 | Semax | |
|---|---|---|
| Category | Cognitive Enhancement | Cognitive Enhancement |
| Regulatory status (US) | Research use only | Compounding (Rx) — Apr 2026 |
| Typical dosage | Research protocols vary | 300-600 mcg |
| Frequency | research | daily |
| Reported benefits | Hippocampal growth, potential depression treatment, cognitive enhancement | Enhanced focus and memory, neuroprotection, improved learning, mood enhancement, stress resilience |
| Reported side effects | Experimental. Side effects under investigation | Generally safe. Possible: overstimulation, sleep disturbances if taken late |
Key differences
Primary use. NSI-189 is categorised under Cognitive Enhancement, while Semax falls under Cognitive Enhancement. Because they target a similar goal, they are common alternatives to weigh against each other.
Regulatory status. NSI-189: not FDA-approved; treated as a research compound. Semax: not FDA-approved; compounding permitted with a prescription as of April 2026.
Dosing. NSI-189 is typically dosed at Research protocols vary (research). Semax is typically dosed at 300-600 mcg (daily).
Can you stack them?
Some protocols combine peptides, but stacking NSI-189 and Semax has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.
Frequently asked questions
- What is the difference between NSI-189 and Semax?
- NSI-189 and Semax are both cognitive enhancement peptides, but they differ in mechanism, dosing, and regulatory status. NSI-189 is not FDA-approved; generally classified as a research compound, whereas Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).
- What is NSI-189 used for?
- Neurogenesis, depression.
- What is Semax used for?
- Cognitive enhancement, focus, memory.
- Can you take NSI-189 and Semax together?
- Some users combine peptides within a single protocol, but stacking NSI-189 and Semax has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
- Is NSI-189 or Semax FDA-approved?
- NSI-189 is not FDA-approved; generally classified as a research compound. Semax is not FDA-approved; compounding permitted with a prescription (as of April 2026).